Pfizer says its anti-COVID pill can reduce the chances of hospitalizations or death by 89 percent for adults at risk of severe illness. The trial results suggest the oral drug outperforms Merck's pill, which just won Britain's approval to treat mild to moderate patients. The Pfizer trial ended early due to its high success rate. U.S. President Joe Biden says the government has secured millions of doses of the Pfizer pill.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3